在这个版本的3 d打印新闻切片,我们甲型肝炎e stories from Ultimaker, KAUST, The ModuLase Project, Johnson Matthey, voxeljet, UbiSoft, Water Pik, LulzBot, SABIC, Sharebot, Organovo, DMG, Dentali…
3D printing news Sliced Boeing, Additive Manufacturing Technologies, TCT, Mcor and TRUMPF
Today’s 3D printing news sliced features updates from Boeing, TCT, Additive Manufacturing Technologies, 3D Hubs, Mcor, TRUMPF, Sintavia, Organovo, DuPont, Haydale Graphene, Shapeways, Builder Ex…
Modern Meadow launches ZOA – the world’s first biofabricated leather
Founded in 2011 Modern Meadow, a spin-out company of 3D bioprinting developer Organovo (NASDAQ:ONVO), has been working on genetically engineered collagen to “grow” animal-friendly meat and…
Organovo reports 11% revenue increase in Q1 2018 due to tissue research demand
Following a demand for tissue development research, 3D bioprinting material provider Organovo (NASDAQ:ONVO) has reported a total revenue of $1.0 million for the first quarter of FY 2018, an 11% increa…
Organovo working with University of Virginia on bioprinting research into muscle reconstruction
Californian bioprinting company Organovo has announced a collaboration with the University of Virginia to utilize bioprinting technology to treat volumetric muscle loss (VML). What is volumetric muscl…
Keith Murphy to step down as CEO of 3D bioprinting company Organovo as commercial market progresses
Management changes across the 3D printing industry continue in 2017 as 3D bioprinting company Organovo Holdings, Inc. (NASDAQ:ONVO) has announces Keith Murphy will be stepping down as CEO. As 3D Print…
Organovo 3D prints the base structure of a human kidney for drug-testing
3D bioprinting company Organovo, (NASDAQ:ONVO) headquartered in San Diego, CA, has published an article showing successful 3D printing of the microscopic veins that make up a kidney. The findings show…
Sliced 3D printing digest: Etihad Airways, 3D printed wheelchair, Renishaw and Leopoly
In this mid week edition of Sliced, we cover 3D printing news featuring: Strata Manufacturing, Siemens and Etihad, Organovo, CloudCities, Renishaw donate to engineering charity, 3D printed wheelchairs…
Organovo 3D bioprinted liver tissue could make it to the FDA by 2019
Speculation on 3D printed tissue coming to humans sooner than we think is backed by new pre-clinical findings from 3D bioprinting company Organovo (NASDAQ:ONVO). Though it will still be 3 – 5 years be…
3D bio-printing will access $3 billion market as Organovo CEO discusses latest results
Organovo CEO Keith Murphy came to the Q2 (FY 2017) analyst and investor call knowing that he would be on the receiving end of some potentially hostile questions. During October shares in the 3D bio-pr…